Sections SEARCH Skip to content Skip to site index Business Day Subscribe Log In Log In Today’s Paper Supported by An employee with a supportive boss is thrilled to learn about a newly created position that will allow her to continue her research. The problem: The job is at a lower classification. ByRob Walker Nov. 2, 2018 Send your workplace conundrums to [email protected] , including your name and contact information (even if you want it withheld). The Workologist is a guy with well-intentioned opinions, not a professional career adviser. Letters may be edited. I’ve recently been performing some of the most rewarding work of my career. And I have always had positive evaluations and have felt supported by my boss. In fact, she has been planning to create a new position to make sure the research I am doing continues well into the future. The first stage will end in the middle of next year, and I have been … [Read more...] about You’ve Been Offered a Great New Job, but Is It Worth a Pay Cut?
Exact sciences jobs
Exact Sciences Corp. is spending more than $300 million to expand its facilities in the Madison area, the company disclosed in documents filed with federal regulators.The filing on Thursday is believed to be the first time Exact Sciences has publicly tallied the extent of its series of construction projects intended to help the company keep up with growing demand for its Cologuard home test kit for colorectal cancer and to develop future cancer testing products.The Madison company is putting an addition onto its Cologuard processing lab on Badger Road and is building a new lab, offices and parking at the former site of Spectrum Brands headquarters, just off Schroeder Road.It also is expanding facilities at two of the three buildings the company occupies in University Research Park, spokesman J.P. Fielder said.Those projects — including construction, equipment and technology — translate into $50.9 million in contracts underway as of March 31 and another $256.8 million … [Read more...] about Exact Sciences’ construction projects top $300 million
Like most students at the time, I did not have access to computer science classes when I attended Wilde Lake High School in Columbia during the 1980s. I only stumbled upon the field when my high school math teacher recommended that I take a FORTRAN programming course at Howard Community College. I quickly learned that programming was like nothing I had experienced in school before. Whenever I finally solved a problem, there was a deeply satisfying “aha!” moment.As a result, I studied computer science at Harvard and received my Ph.D. in the field from the University of California, Berkeley. Nearly four decades after I took that first FORTRAN class, I’m a professor of computer science and associate dean at the University of Maryland, Baltimore County.I was fortunate to have found my passion, even though computer science was not taught at my school. The unfortunate fact is that most K-12 schools still do not teach computer science, and most of today’s high school … [Read more...] about All kids should have a computer science education
Linette Lopez, provided by Published 2:46 pm, Wednesday, April 11, 2018 Reuters Mallinckrodt Pharmaceuticals' blockbuster drug Acthar has been one of the biggest drug-related expenses for the government's Medicare program. In 2015 alone Medicare spent $500 million on it. The drug is primarily indicated to treat infantile spasms. Medicare is a program for the elderly. One whistleblower claims that Mallinckrodt has engaged in an elaborate scheme to push the drug on payers, and hide the fact that no one at the company actually knows what's in it. What's more, says the whistleblower, Mallinckrodt couldn't have done it without the help of the biggest pharmacy benefit manager in the country. Mallinckrodt said in a statement: "The company vehemently disagrees with the allegations made in the complaint and intends to vigorously defend itself in this matter." Business Channel Now Playing: Now Playing Bobbi Brown: "I Study Instagram" Cheddar TV … [Read more...] about ‘There’s other s— in the vial’: Bombshell lawsuit claims no one knows exactly what’s in a drug that’s cost the government over $1 billion
Visit The Boston Globe Share on Twitter Share on Facebook Comment on this Scroll to top of page By Cindy Atoji Keene Globe Correspondent April 05, 2018 Crime lab chemist Annie Dookhan was a classic failure. That’s according to veteran forensic expert Robin Cotton, who was horrified as she watched the Massachusetts crime lab scandal unfold six years ago. Dookhan falsified evidence in thousands of drug-related court cases. As a forensic practitioner herself, Cotton says, she understands the pressures scientists can face from heavy caseloads, law enforcement, and exposure to horrifyingly violent crime scenes. “A lab chemist can somehow get it into their head that they are there to facilitate the prosecution. But really we are here to come to the best and just answer, which is not always clear cut,” says Cotton, who has testified in more than 200 criminal cases, most revolving around DNA identification.As director of Boston University’s … [Read more...] about This forensic science expert has testified in some notorious cases